Evidence map›Paper›PMID 41757880›Full record

ArticleMicrobiology spectrum2026

A photoactivation-free viability PCR reagent for rapid, culture-independent detection of live bacteria.

Nathan Feirer, Matthew Poole, Nishanth Kuchi, Caitlin Hawthorn, Rebecca Marino, James J Cali, Attiq Rehman, Diane Botelho, Subhanjan Mondal

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nathan FeirerPromega Corporation, Fitchburg, Wisconsin, USA.ORCID 0000-0001-7833-8341
Matthew PooleResearch and Productivity Council (RPC), Moncton, New Brunswick, Canada.
Nishanth KuchiResearch and Productivity Council (RPC), Moncton, New Brunswick, Canada.
Caitlin HawthornPACE Analytical, Pittsburgh, Pennsylvania, USA.
Rebecca MarinoPACE Analytical, Pittsburgh, Pennsylvania, USA.
James J CaliPromega Corporation, Fitchburg, Wisconsin, USA.
Attiq RehmanResearch and Productivity Council (RPC), Moncton, New Brunswick, Canada.
Diane BotelhoResearch and Productivity Council (RPC), Moncton, New Brunswick, Canada.
Subhanjan MondalPromega Corporation, Fitchburg, Wisconsin, USA.

Funding

New Brunswick Regional Development Corporation 15847
6 · The paper itself

Abstract

Detection of viable bacteria in complex samples is a long-standing challenge in microbiology and public health. Traditional culture methods are slow and often fail to capture viable but non-culturable cells, while PCR-based methods can overestimate bacterial loads by amplifying DNA from non-viable (dead) cells. To address this challenge, we evaluated a novel, photoactivation-free viability PCR (vPCR) reagent from Promega Corporation that selectively crosslinks DNA from non-viable cells, rendering it unamplifiable by qPCR. This approach enables accurate, culture-independent quantification of viable bacteria. We optimized key parameters in both gram-positive ( IMPORTANCE: Rapid and reliable detection of viable bacteria is essential for protecting public health, monitoring water quality, ensuring food safety, and advancing clinical diagnostics. Conventional culture methods underestimate viable cells and require days to deliver results, while conventional PCR-based tests cannot distinguish viable (live) from non-viable (dead) organisms. Here, we describe a photoactivation-free viability PCR reagent that overcomes these limitations by selectively blocking PCR amplification from non-viable cells. Using

Indexed as

BacteriaMicrobial ViabilityPolymerase Chain ReactionDNA, BacterialLegionellaWater MicrobiologyDNA, Bacterialbacterial viabilityLegionellaqPCRviability PCR

Identifiers

PMID41757880
PMCPMC13055399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.